Yield10 Bioscience

Yield10 Bioscience Stock-Based Compensation

The Stock-Based Compensation (SBC) of Yield10 Bioscience (YTENQ) as of Nov 3, 2026 is 1.59 M USD. In the previous year, Stock-Based Compensation (SBC) was 1.90 M USD — a change of -16.34% (lower).

Stock-Based Compensation

1.59 MUSD

YoY

-16.34%

Last updated:

Stock-Based Compensation (SBC) of Yield10 Bioscience is 2023 1.59 M USD. Stock-Based Compensation (SBC) of Yield10 Bioscience was 2022 1.90 M USD. It decreases by -16.34% lower compared to the previous year.

The Yield10 Bioscience Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2016
848,000.00 USD
Jan 1, 2017
1.40 M USD
Jan 1, 2018
1.18 M USD
Jan 1, 2019
656,000.00 USD
Jan 1, 2020
739,000.00 USD
Jan 1, 2021
1.68 M USD
Jan 1, 2022
1.90 M USD
Jan 1, 2023
1.59 M USD
The Yield10 Bioscience Stock-Based Compensation history
YEARStock-Based CompensationYoY
1.59 MUSD-16.34%
1.90 MUSD+13.61%
1.68 MUSD+126.66%
739,000.00USD+12.65%
656,000.00USD-44.45%
1.18 MUSD-15.34%
1.40 MUSD+64.50%
848,000.00USD-60.15%
2.13 MUSD-8.87%
2.34 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yield10 Bioscience Stock analysis

What does Yield10 Bioscience do? Yield10 Bioscience develops Camelina sativa as a platform crop for low carbon sustainable seed products, including Camelina oil for biofuel feedstock, Omega-3 oils for nutrition, and PHA Bioplastics for biodegradable packaging. The company uses its TraitFactory platform to discover genetic traits for agriculture and food industries, focusing on herbicide tolerance and disease resistance in Camelina germplasm. Its products target petroleum replacement markets, food and nutrition sectors, and animal feed markets, with development pipelines focused on improving Camelina varieties. The company's primary products are Camelina oil, Omega-3 oils, and PHA Bioplastics, sold to markets addressing petroleum replacement, nutrition, and sustainable packaging needs. Camelina sativa serves as the core crop for all seed product development, with TraitFactory enabling trait discovery for agricultural and food applications. The firm targets industrial buyers in biofuel, nutrition, and packaging industries seeking sustainable alternatives to petroleum-based products. Yield10 Bioscience's revenue streams come from the sale of Camelina-based products to companies in the biofuel, nutrition, and packaging sectors. The company focuses on developing high-value genetic traits through TraitFactory, which are integrated into Camelina varieties for large-scale production of seed products. Its development pipeline emphasizes traits like herbicide tolerance and disease resistance to enhance crop performance and market appeal. Yield10 Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Yield10 Bioscience stock

Stock-Based Compensation (SBC) of Yield10 Bioscience is 1.59 M USD in 2023.

Stock-Based Compensation (SBC) of Yield10 Bioscience changed from 1.90 M USD to 1.59 M USD, representing a -16.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Yield10 Bioscience since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Yield10 Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Yield10 Bioscience

All Key Metrics — Yield10 Bioscience